<HashMap><database>biostudies-literature</database><scores/><additional><submitter>O'Connor KW</submitter><funding>NIAID NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>HHS | NIH | National Institute of Allergy and Infectious Diseases</funding><funding>NCI NIH HHS</funding><funding>Division of Intramural Research, National Institute of Allergy and Infectious Diseases</funding><pagination>e2220853120</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10469339</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>120(35)</volume><pubmed_abstract>Ly6C&lt;sup>lo&lt;/sup> monocytes are a myeloid subset that specializes in the surveillance of vascular endothelium. Ly6C&lt;sup>lo&lt;/sup> monocytes have been shown to derive from Ly6C&lt;sup>hi&lt;/sup> monocytes. NOTCH2 signaling has been implicated as a trigger for Ly6C&lt;sup>lo&lt;/sup> monocyte development, but the basis for this effect is unclear. Here, we examined the impact of NOTCH2 signaling of myeloid progenitors on the development of Ly6C&lt;sup>lo&lt;/sup> monocytes in vitro. NOTCH2 signaling induced by delta-like ligand 1 (DLL1) efficiently induced the transition of Ly6C&lt;sup>hi&lt;/sup> TREML4&lt;sup>-&lt;/sup> monocytes into Ly6C&lt;sup>lo&lt;/sup> TREML4&lt;sup>+&lt;/sup> monocytes. We further identified two additional transcriptional requirements for development of Ly6C&lt;sup>lo&lt;/sup> monocytes. Deletion of BCL6 from myel</pubmed_abstract><journal>Proceedings of the National Academy of Sciences of the United States of America</journal><pubmed_title>&lt;i>Bcl6&lt;/i>, &lt;i>Irf2&lt;/i>, and &lt;i>Notch2&lt;/i> promote nonclassical monocyte development.</pubmed_title><pmcid>PMC10469339</pmcid><funding_grant_id>R01AI162643</funding_grant_id><funding_grant_id>R01 CA248919</funding_grant_id><funding_grant_id>R21 AI164142</funding_grant_id><funding_grant_id>R01 AI162643</funding_grant_id><funding_grant_id>R01 HL140622</funding_grant_id><funding_grant_id>R01AI150297</funding_grant_id><funding_grant_id>R01 AI150297</funding_grant_id><pubmed_authors>Kim S</pubmed_authors><pubmed_authors>Georgopoulos K</pubmed_authors><pubmed_authors>Briseno CG</pubmed_authors><pubmed_authors>O'Connor KW</pubmed_authors><pubmed_authors>Murphy TL</pubmed_authors><pubmed_authors>Liu T</pubmed_authors><pubmed_authors>Murphy KM</pubmed_authors></additional><is_claimable>false</is_claimable><name>&lt;i>Bcl6&lt;/i>, &lt;i>Irf2&lt;/i>, and &lt;i>Notch2&lt;/i> promote nonclassical monocyte development.</name><description>Ly6C&lt;sup>lo&lt;/sup> monocytes are a myeloid subset that specializes in the surveillance of vascular endothelium. Ly6C&lt;sup>lo&lt;/sup> monocytes have been shown to derive from Ly6C&lt;sup>hi&lt;/sup> monocytes. NOTCH2 signaling has been implicated as a trigger for Ly6C&lt;sup>lo&lt;/sup> monocyte development, but the basis for this effect is unclear. Here, we examined the impact of NOTCH2 signaling of myeloid progenitors on the development of Ly6C&lt;sup>lo&lt;/sup> monocytes in vitro. NOTCH2 signaling induced by delta-like ligand 1 (DLL1) efficiently induced the transition of Ly6C&lt;sup>hi&lt;/sup> TREML4&lt;sup>-&lt;/sup> monocytes into Ly6C&lt;sup>lo&lt;/sup> TREML4&lt;sup>+&lt;/sup> monocytes. We further identified two additional transcriptional requirements for development of Ly6C&lt;sup>lo&lt;/sup> monocytes. Deletion of BCL6 from myel</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Aug</publication><modification>2025-04-18T13:13:44.816Z</modification><creation>2025-04-06T22:45:54.987Z</creation></dates><accession>S-EPMC10469339</accession><cross_references><pubmed>37607223</pubmed><doi>10.1073/pnas.2220853120</doi></cross_references></HashMap>